-
2023
-
AZ, Sanofi get first green light for RSV prophylactic antibody
-
Daiichi Sankyo’s Quizartinib Gets Priority Review for Newly Diagnosed Leukemia
-
Tiziana Life Sciences Plans IND for Phase 1 Study of Intranasal Foralumab in Alzheimer Disease
-
New Agents, Clinical Research Promise More Personalized Treatment for Patients with Diabetic Kidney Disease, Type 2 Diabetes
-
Acumen Antibody Granted Fast Track Designation for Alzheimer’s Disease
-
Vanda Pharmaceuticals Gains Orphan Drug Status for Investigational Cholera Drug
-
J&J nabs FDA okay for BCMA bispecific Tecvayli
-
NovAccess Global Gains Orphan Drug Status for Brain Cancer Drug Candidate
-
GSK shelves arthritis blockbuster hope otilimab after lacklustre data
-
Cladribine Shows Efficacy, Tolerability Among Patients With MS Switching From Infusion DMTs